Is escapism a way to cope with reality or, as the word implies, an attempt to slowly and permanently escape from it? Does escapism have levels to it, and when is it dangerous? I’ll admit I’m an escapist. I’m a former pothead who lost way too many brain cells to…
There’s been much excitement lately around artificial intelligence (AI) — especially since generative AI became widely accessible. What used to be a complex, almost unreachable tool is now part of daily conversations, transforming the way we work, learn, and live. It brings a mix of emotions: optimism that it could…
People with generalized myasthenia gravis (gMG) who were misdiagnosed at least once and who have certain disease symptoms are more likely to see an increase in disease severity, according to a recent study. Ocular symptoms and/or muscle aches after physical activity were significantly associated with a higher risk of…
Rituximab may be safe and effective in treating young children with myasthenia gravis (MG) driven by antibodies that target muscle-specific tyrosine kinase (MuSK), according to a report detailing the case of a 4-year-old girl. The girl was one of the youngest MG patients to have received rituximab, according…
Disease-causing antibodies from different myasthenia gravis (MG) patients bind to and affect the function of acetylcholine receptors (AChRs) in different ways, a study finds. While the mechanism varied, all the antibodies ultimately interfered with the usual activation of AChRs, which are the proteins important for normal muscle contractions commonly…
Someone recently left a comment on one of my columns that made me pause and lean in. They wrote that myasthenia gravis (MG) isn’t rare; it’s just underdiagnosed. Oofta. That one hit like a whisper with a punch. Because on the surface, it feels true. Many of us with…
Talk show host Conan O’Brien, among many others, once said, “When all else fails, there is always delusion.” As human beings, we want to believe what we want to believe, even when red flags and truth indicators warn us of the contrary. It can be comforting to embrace delusion when…
I recently made peace with the fact that we almost always judge the book by its cover. It’s just what humans do. We believe what we see. And having a disease that’s not always visible has been the biggest challenge of my life. I often look just tired enough to…
Long-term treatment with nipocalimab led to sustained reductions in symptom severity among antibody-positive patients with generalized myasthenia gravis (gMG) in a Phase 3 clinical trial. That’s according to new data presented by its developer, Johnson & Johnson, at the American Academy of Neurology (AAN) Annual Meeting this…
Treatment with Remegen’s telitacicept over nearly six months safely reduced disease severity in adults with generalized myasthenia gravis (gMG) and helped ease these patients’ symptoms. That’s according to new data from a Phase 3 clinical trial (NCT05737160) that was presented in a late-breaking session at this year’s…
Get regular updates to your inbox.
